<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04331769</url>
  </required_header>
  <id_info>
    <org_study_id>5019</org_study_id>
    <nct_id>NCT04331769</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study</brief_title>
  <official_title>Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ancora Heart, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ancora Heart, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, randomized, open-label, international, multi-center clinical study to evaluate&#xD;
      the safety and efficacy of the AccuCinch Ventricular Restoration System in patients with&#xD;
      heart failure and reduced ejection fraction (HFrEF).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The CORCINCH-HF Study is a prospective, randomized, open-label, multicenter, international,&#xD;
      clinical safety and efficacy investigation of the AccuCinch Ventricular Restoration System.&#xD;
&#xD;
      Subjects will be randomized in a 1:1 ratio:&#xD;
&#xD;
        1. Treatment group: AccuCinch Ventricular Restoration System plus guideline-directed&#xD;
           medical therapy (GDMT) (n~200)&#xD;
&#xD;
        2. Control group: Guideline-directed medical therapy (GDMT) (n~200)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2020</start_date>
  <completion_date type="Anticipated">December 21, 2030</completion_date>
  <primary_completion_date type="Anticipated">June 21, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freedom from device- or femoral artery access-related major adverse events (MAE)</measure>
    <time_frame>180 days</time_frame>
    <description>MAE defined as:&#xD;
All-cause death,&#xD;
Myocardial infarction,&#xD;
Stroke,&#xD;
Need for non-elective cardiovascular surgery,&#xD;
Worsening of heart-failure requiring mechanical circulatory support for more than 24 hours&#xD;
Acute kidney injury requiring renal replacement therapy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in Kansas City Cardiomyopathy Questionnaire Quality of Life Questionnaire (KCCQ) Score</measure>
    <time_frame>180 days</time_frame>
    <description>Higher scores in the KCCQ reflect better health status</description>
  </primary_outcome>
  <primary_outcome>
    <measure>6-Minute Walk Test (6MWT) distance (m)</measure>
    <time_frame>180 days</time_frame>
    <description>Change in 6MWT distance (m) from baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Freedom from device- or femoral artery access-related major adverse events (MAE)</measure>
    <time_frame>365 days</time_frame>
    <description>MAE defined as:&#xD;
All-cause death,&#xD;
Myocardial infarction,&#xD;
Stroke,&#xD;
Need for non-elective cardiovascular surgery,&#xD;
Worsening of heart-failure requiring mechanical circulatory support for more than 24 hours&#xD;
Acute kidney injury requiring renal replacement therapy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>A hierarchical composite endpoint of all-cause deaths, left ventricular assist device (LVAD) implants or heart transplants, heart failure hospitalizations, and changes from baseline in Kansas City Cardiomyopathy Questionnaire Overall Score (KCCQ-OS)</measure>
    <time_frame>365 days</time_frame>
    <description>A hierarchical composite endpoint of number of all-cause deaths, number of left ventricular assist device (LVAD) implants or heart transplants, number of heart failure hospitalizations, and change from baseline in Kansas City Cardiomyopathy Questionnaire Overall Score (KCCQ-OS), evaluated using the Win Ratio method</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of all-cause deaths or all-cause hospitalizations</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 545 days, 730 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of all-cause deaths</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 545 days, 730 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of all-cause hospitalizations</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 545 days, 730 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of all serious adverse events, including device- and procedure- related complications</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 545 days, 730 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from baseline in New York Heart Association (NYHA) functional class</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 545 days, 730 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from baseline in Kansas City Cardiomyopathy Questionnaire Overall Score (KCCQ-OS)</measure>
    <time_frame>30 days, 90 days, 365 days, 545 days, 730 days</time_frame>
    <description>Higher scores in the KCCQ reflect better health status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from baseline in 6-Minute Walk Test (6MWT)</measure>
    <time_frame>30 days, 90 days, 365 days, 545 days, 730 days</time_frame>
    <description>Measure in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in left ventricular ejection fraction (LVEF) from baseline and from post-procedure/pre-hospital discharge as assessed by echo</measure>
    <time_frame>30 days, 90 days, 365 days, 730 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in left ventricular ejection fraction (LVEF) from baseline and from post-procedure/pre-hospital discharge as assessed by echo and CT</measure>
    <time_frame>180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in left ventricular end-diastolic volume (LVEDV) from baseline and from post-procedure/pre-hospital discharge as assessed by echo</measure>
    <time_frame>30 days, 90 days, 365 days, 730 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in left ventricular end-diastolic volume (LVEDV) from baseline and from post-procedure/pre-hospital discharge as assessed by echo and CT</measure>
    <time_frame>180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in left ventricular end-systolic volume (LVESV) from baseline and from post-procedure/pre-hospital discharge as assessed by echo</measure>
    <time_frame>30 days, 90 days, 365 days, 730 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in left ventricular end-systolic volume (LVESV) from baseline and from post-procedure/pre-hospital discharge as assessed by echo and CT</measure>
    <time_frame>180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate and number of cardiovascular death events</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 545 days, 730 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate and number of heart failure death events</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 545 days, 730 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate and number of heart failure-related hospitalizations</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 545 days, 730 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes from baseline in mitral effective regurgitant orifice area (EROA)</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 730 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes from baseline in left atrial strain measured by Echo</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 730 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes from baseline in left ventricular global longitudinal strain measured by Echo</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 730 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes from baseline in right ventricular free wall longitudinal strain measured by Echo</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 730 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes from baseline in Kansas City Cardiomyopathy Questionnaire (KCCQ) individual domains</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 545 days, 730 days</time_frame>
    <description>Higher scores in the KCCQ reflect better health status</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes from baseline in EuroQol Five Dimension Five Level (EQ-5D-5L) Quality of Life Questionnaire</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 545 days, 730 days</time_frame>
    <description>Lower scores in the EQ-5D-5L reflect better health status</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes from baseline in right ventricular (RV) fractional area change measured by Echo</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 730 days</time_frame>
    <description>Measured by percent change</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes from baseline in tricuspid annular plane systolic excursion (TAPSE) measured by Echo</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 730 days</time_frame>
    <description>Measured in centimeters or millimeters</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes from baseline in tricuspid regurgitation measured by Echo</measure>
    <time_frame>30 days, 90 days, 180 days, 365 days, 730 days</time_frame>
    <description>Measured using effective regurgitant orifice area (mm2) and regurgitant volume (mL)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Heart Failure With Reduced Ejection Fraction (HFrEF)</condition>
  <condition>Dilated Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>Device group: AccuCinch Ventricular Restoration System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this arm will receive the AccuCinch Ventricular Restoration System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group: Guideline-Directed Medical Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in this arm will receive guideline-directed medical therapy (GDMT)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AccuCinch Ventricular Restoration System</intervention_name>
    <description>AccuCinch Ventricular Restoration System</description>
    <arm_group_label>Device group: AccuCinch Ventricular Restoration System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Guideline-Directed Medical Therapy</intervention_name>
    <description>Guideline-Directed Medical Therapy</description>
    <arm_group_label>Control group: Guideline-Directed Medical Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18-years or older&#xD;
&#xD;
          2. Ejection Fraction: ≥20% and ≤40% measured by transthoracic echocardiography (TTE) and&#xD;
             assessed by an echocardiography (echo) core lab&#xD;
&#xD;
          3. LV end-diastolic diameter ≥55 mm measured by TTE and assessed by an echo core lab&#xD;
&#xD;
          4. Symptom Status:&#xD;
&#xD;
               1. NYHA III,&#xD;
&#xD;
               2. NYHA ambulatory IV, or&#xD;
&#xD;
               3. NYHA II with a heart failure hospitalization within the prior 12 months (of&#xD;
                  signing the consent)&#xD;
&#xD;
          5. Able to complete six-minute walk test with distance between 100 m and 450 m.&#xD;
&#xD;
          6. Diagnosis and treatment for heart failure should be established at least 90 days&#xD;
             before the date of consent. Subjects should be on stable, optimally titrated medical&#xD;
             therapy for at least 30 days, as recommended according to current guidelines as&#xD;
             standard-of-care for Heart Failure therapy, with any intolerance documented.&#xD;
&#xD;
               1. &quot;Stable&quot; is defined as no more than a 100% increase or a 50% decrease of total&#xD;
                  daily doses. Medication changes within this range do not require any additional&#xD;
                  waiting before the screening assessments&#xD;
&#xD;
               2. When a total daily dose increase or decrease exceeds that which is considered&#xD;
                  stable, the screening TTE and CT will be postponed 30 days after the medication&#xD;
                  change&#xD;
&#xD;
               3. When additional titration is required to optimize a subject's medication that&#xD;
                  exceeds what is considered stable, the screening TTE and CT will be postponed at&#xD;
                  least 30 days after achieving the optimal dose (provided the optimal dose remains&#xD;
                  outside of the stable parameters)&#xD;
&#xD;
               4. When a dose-for-dose equivalent change in the class of medication change is made,&#xD;
                  no additional waiting is required before the screening assessments&#xD;
&#xD;
               5. When a change in class medication change exceeds what is considered stable, OR a&#xD;
                  new class of medication is added, the screening TTE and CT will be postponed 30&#xD;
                  days after the medication change&#xD;
&#xD;
               6. If an SGLT2 inhibitor is added to a subject's medications, the screening TTE and&#xD;
                  CT will be postponed at least 30 days after the addition&#xD;
&#xD;
               7. If an SGLT2 inhibitor dose changes per the stable definition above, no additional&#xD;
                  waiting is required before the screening assessments&#xD;
&#xD;
               8. If an SGLT2 inhibitor dose change exceeds what is considered stable, the&#xD;
                  screening TTE and CT will be postponed at least 30 days after achieving the&#xD;
                  optimal dose (provided the dose remains outside of the stable parameters)&#xD;
&#xD;
               9. When applicable, for guideline-directed device-based therapies: a CRT device must&#xD;
                  be placed &gt; 90 days before the screening TTE and CT, and an ICD must be placed &gt;&#xD;
                  30 days before the screening TTE and CT&#xD;
&#xD;
          7. Able and willing to complete all qualifying diagnostic and functional tests, willing&#xD;
             to accept blood product transfusion if required and agrees to comply with study&#xD;
             follow-up schedule&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Cardiovascular&#xD;
&#xD;
          1. Myocardial infarction or any percutaneous cardiovascular intervention, cardiovascular&#xD;
             surgery, or carotid surgery within 90 days prior to consent&#xD;
&#xD;
          2. Untreated clinically significant coronary artery disease (CAD) requiring&#xD;
             revascularization&#xD;
&#xD;
          3. Fluoroscopic or echocardiographic evidence of severe aortic arch calcification, mobile&#xD;
             aortic atheroma, intracardiac mass, thrombus or vegetation&#xD;
&#xD;
          4. Suboptimal ventricular anatomy or wall thickness as determined from screening&#xD;
             echocardiography and/or CT scan&#xD;
&#xD;
          5. Heart failure on the basis other than ischemic or non-ischemic dilated cardiomyopathy&#xD;
             (e.g., hypertrophic cardiomyopathy, amyloid cardiomyopathy, restrictive&#xD;
             cardiomyopathy, uncorrected congenital heart disease, constrictive pericarditis)&#xD;
&#xD;
          6. Hemodynamic instability within 30 days prior to the implant defined as subject&#xD;
             requiring inotropic support or mechanical hemodynamic support&#xD;
&#xD;
          7. Any planned cardiac surgery or interventions within the next 180 days&#xD;
             post-randomization (including therapeutic right heart procedures)&#xD;
&#xD;
          8. Active bacterial endocarditis&#xD;
&#xD;
          9. Severe RV dysfunction assessed by right heart catheterization (RHC) and/or TTE&#xD;
&#xD;
         10. Fixed pulmonary hypertension with PA systolic pressure &gt;70 mmHg not responsive to&#xD;
             vasodilator therapy&#xD;
&#xD;
         11. History of any stroke within the prior 90 days of consent or documented Modified&#xD;
             Rankin Scale ≥ 2 disability from any prior stroke&#xD;
&#xD;
             Valvular&#xD;
&#xD;
         12. Mitral regurgitation grade 3+ (moderate-severe) or 4+ (severe)&#xD;
&#xD;
         13. Untreated degenerative (primary) mitral valve disease (mild prolapse with no need for&#xD;
             intervention is allowable)&#xD;
&#xD;
         14. Prior mitral or aortic valve replacement&#xD;
&#xD;
         15. Tricuspid regurgitation grade 4+ (severe)&#xD;
&#xD;
         16. Moderate or severe aortic valve stenosis (AVA less than 1.5 cm2 or peak velocity AV&#xD;
             Vmax &gt;300 cm/sec)&#xD;
&#xD;
         17. Aortic regurgitation grade 2+ (moderate), 3+ (moderate-severe), or 4+ (severe)&#xD;
&#xD;
             Procedural&#xD;
&#xD;
         18. Anatomical pathology or constraints preventing appropriate access/implant of the&#xD;
             AccuCinch Ventricular Restoration System (e.g., femoral arteries will not support a&#xD;
             20F Introducer sheath)&#xD;
&#xD;
         19. Renal insufficiency (i.e., eGFR of &lt;25 ml/min/1.73 m2)&#xD;
&#xD;
         20. Subjects in whom anticoagulation during the procedure is contraindicated&#xD;
&#xD;
         21. Subjects in whom 90 days of antiplatelet therapy is contraindicated&#xD;
&#xD;
         22. Known allergy to nitinol, polyester, or polyethylene&#xD;
&#xD;
         23. Any prior true anaphylactic reaction to contrast agents; defined as known&#xD;
             anaphylactoid or other non-anaphylactic allergic reactions to contrast agents that&#xD;
             cannot be adequately pre-medicated prior to the index procedure&#xD;
&#xD;
             General&#xD;
&#xD;
         24. Life expectancy &lt;1 year due to non-cardiac conditions&#xD;
&#xD;
         25. Currently participating in another interventional investigational study&#xD;
&#xD;
         26. Subjects on high dose steroids or immunosuppressant therapy&#xD;
&#xD;
         27. Female subjects who are pregnant, of child-bearing potential without a documented&#xD;
             birth control method, or who are lactating&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin B Leon, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulrich P Jorde, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center/Albert Einstein College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Reisman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Presbyterian/Weill Cornell Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Zapien, MS, CCRA</last_name>
    <phone>408-727-1105</phone>
    <email>mzapien@ancoraheart.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Grandview Medical Group Research, LLC</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susan Thorington, RN</last_name>
      <phone>205-971-7578</phone>
      <email>Susan.thorington@grandviewhealth.com</email>
    </contact>
    <investigator>
      <last_name>Juan Bernal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tucson Medical Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Natalia Elias Calles, MPH</last_name>
      <phone>520-324-5512</phone>
      <email>natalia.eliascalles@tmcaz.com</email>
    </contact>
    <investigator>
      <last_name>Thomas E. Waggoner, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maylene Alegre</last_name>
      <phone>858-246-2511</phone>
      <email>malegre@health.ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Jorge Silva Enciso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scripps Health</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Matthew Price, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Quyen Chau</last_name>
      <phone>415-833-3468</phone>
      <email>Quyen.x.chau@kp.org</email>
    </contact>
    <investigator>
      <last_name>Van Selby, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Furrier</last_name>
      <phone>415-476-4922</phone>
      <email>Jacqueline.Furrier@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Liviu Klein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tara Churney</last_name>
      <phone>303-724-6473</phone>
      <email>TARA.CHURNEY@CUANSCHUTZ.ED</email>
    </contact>
    <investigator>
      <last_name>Andreas Brieke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hartford Health</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>William Roman</last_name>
      <phone>860-972-1558</phone>
      <email>William.Roman@hhchealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Raymond McKay, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Levesque, RN</last_name>
      <phone>203-737-6483</phone>
      <email>Linda.levesque@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Lavanya Bellumkonda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medstar Health Research Institute</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Deville</last_name>
      <phone>202-553-6960</phone>
      <email>Michelle.Deville@Medstar.net</email>
    </contact>
    <investigator>
      <last_name>Samer Najjar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>JFK Medical Center</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>33462</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zarah Agustin, RN</last_name>
      <email>Zarah.Agustin@SarahCannon.com</email>
    </contact>
    <investigator>
      <last_name>Waqas Ghumman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Delray Medical Center</name>
      <address>
        <city>Delray Beach</city>
        <state>Florida</state>
        <zip>33484</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christopher Minnerly</last_name>
      <phone>561-799-5431</phone>
      <email>christopher.minnerly@tenethealth.com</email>
    </contact>
    <investigator>
      <last_name>Brijeshwar Maini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Barbara Lang</last_name>
      <phone>305-298-4471</phone>
      <email>BLang@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Mrudula Munagala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nhi Tran</last_name>
      <phone>813-259-0628</phone>
      <email>nntran@usf.edu</email>
    </contact>
    <investigator>
      <last_name>Fadi Matar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristy Pitts</last_name>
      <phone>404-686-5775</phone>
      <email>klpitts@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Kendra Grubb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariam Nuhu</last_name>
      <email>mariam.nuhu@piedmont.org</email>
    </contact>
    <investigator>
      <last_name>Benjamin DeMoss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meredith Chappell</last_name>
      <phone>312-926-7312</phone>
      <email>Meredith.Chappell@nm.org</email>
    </contact>
    <investigator>
      <last_name>James Flaherty, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amy Bennett</last_name>
      <email>abennett4@medicine.bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Gene Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advocate Good Samaritan Hospital</name>
      <address>
        <city>Downers Grove</city>
        <state>Illinois</state>
        <zip>60515</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jill Lux</last_name>
      <phone>630-730-6343</phone>
      <email>Jillian.Lux@aah.org</email>
    </contact>
    <investigator>
      <last_name>Ali Valika, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northshore University Health Systems</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ujala Bokhary</last_name>
      <phone>847-570-2089</phone>
      <email>UBokhary@northshore.org</email>
    </contact>
    <investigator>
      <last_name>Mark Ricciardi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Institute of the South</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deanna Benoit, LPN, CCRC</last_name>
      <phone>985-873-5613</phone>
      <email>Deanna.Benoit@cardio.com</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Aucoin, LPN, CCRC</last_name>
      <phone>985-873-5037</phone>
      <email>Jennifer.aucoin@cardio.com</email>
    </contact_backup>
    <investigator>
      <last_name>Peter Fail, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vanessa Palumo</last_name>
      <phone>617-636-9334</phone>
      <email>vpalomo@tuftsmedicalcenter.org</email>
    </contact>
    <investigator>
      <last_name>Navin Kapur, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lina Fu</last_name>
      <email>LFU2@PARTNERS.ORG</email>
    </contact>
    <investigator>
      <last_name>Ignacio Inglessis-Azuaje, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Tyler, MSRN, FNP-c</last_name>
      <phone>617-632-7727</phone>
      <email>ptyler@bidmc.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jenifer Kaufman, RN, MS</last_name>
      <phone>617-632-8956</phone>
      <email>jmkaufma@bidmc.harvard.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Arthur Rashad Garan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Helm</last_name>
      <phone>616-486-2080</phone>
      <email>Elizabeth.Helm@spectrumhealth.org</email>
    </contact>
    <investigator>
      <last_name>Sangjin Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute Foundation</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kari Thomas</last_name>
      <email>Kari.M.Thomas@allina.com</email>
    </contact>
    <investigator>
      <last_name>Peter Eckman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55414</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Coley Landvik</last_name>
      <phone>612-625-3475</phone>
      <email>clandvik@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory Helmer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jackson Heart Clinic</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie Neal, RN</last_name>
      <phone>602-982-7850</phone>
      <email>JNeal@jacksonheart.com</email>
    </contact>
    <investigator>
      <last_name>William Crowder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University in St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Flanagan</last_name>
      <phone>314-454-7451</phone>
      <email>jflanaga@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Justin Vader, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Canino</last_name>
      <phone>551-996-3775</phone>
      <email>Peter.Canino@hmhn.org</email>
    </contact>
    <investigator>
      <last_name>Tilak Pasala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Diane Agar</last_name>
      <phone>973-971-4205</phone>
      <email>Diane.agar@atlantichealth.org</email>
    </contact>
    <investigator>
      <last_name>Philippe Genereux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Peter's Health Partners Medical Associates</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>PeggySue Schaummann-Boyle</last_name>
      <email>Peggy.Schaummann-Boyle@sphp.com</email>
    </contact>
    <investigator>
      <last_name>Nish Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Cabral</last_name>
      <phone>718-920-4595</phone>
      <email>DCabral@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Mohamed Azeem Latib, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristine McGowan, DNP, ANP-BC</last_name>
      <phone>516-562-2345</phone>
      <email>KMcGowan@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Gerin Stevens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Betsy Ellsworth, MSN, ANP</last_name>
      <phone>212-824-8902</phone>
      <email>Betsy.ellsworth@mountsinai.orgorg</email>
    </contact>
    <contact_backup>
      <last_name>Esther Peña</last_name>
      <phone>212-824-8909</phone>
      <email>esther.pena@mountsinai.org</email>
    </contact_backup>
    <investigator>
      <last_name>Vivek Reddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CUMC/New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Dalton</last_name>
      <phone>212-342-1820</phone>
      <email>keb2114@columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Gabriel Sayer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medicine-New York Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dolores Reynolds</last_name>
      <phone>212-746-4617</phone>
      <email>Dtr2001@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Shing Chiu Wong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vassar Brothers Medical Center</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Rausch</last_name>
      <phone>845-483-6323</phone>
      <email>William.rausch@nuvancehealth.org</email>
    </contact>
    <investigator>
      <last_name>Rajeev Narayan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Krug, MA, RN CCRC</last_name>
      <phone>516-562-6722</phone>
      <email>patricia.krug@chsli.org</email>
    </contact>
    <contact_backup>
      <last_name>Elizabeth Haag, RN, MPA, CCRP</last_name>
      <phone>516-662-4512</phone>
      <email>Elizabeth.Haag@chsli.org</email>
    </contact_backup>
    <investigator>
      <last_name>George Petrossian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denise Krabbe</last_name>
      <phone>513-585-1777</phone>
      <email>denise.krabbe@thechristhospital.com</email>
    </contact>
    <investigator>
      <last_name>Satya Shreenvias, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UH Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Mangene</last_name>
      <phone>216-844-4950</phone>
      <email>Samantha.Mangene@uhhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Guilherme Attizzani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Molly Savanick</last_name>
      <phone>216-445-6397</phone>
      <email>SAVANIM@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Rishi Puri, MD PhD FRACP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexa Coressel</last_name>
      <phone>614-247-7133</phone>
      <email>Alexa.Coressel@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Konstantinos D Boudoulas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>INTEGRIS Baptist Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dellia Dion</last_name>
      <email>Dellia.Dion@integrisok.com</email>
    </contact>
    <investigator>
      <last_name>Douglas Horstmanshof, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Hospital</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacie Hanes, APRN-CNS, CCRN, CCRC</last_name>
      <phone>405-608-1283</phone>
      <email>shanes@okheart.com</email>
    </contact>
    <contact_backup>
      <last_name>Donna Grossman, RN, CCRC</last_name>
      <phone>405-608-1272</phone>
      <email>dgrossman@okheart.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mohammad Ghani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence St. Vincent Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivia Derridinger</last_name>
      <phone>503-216-7275</phone>
      <email>Olivia.Derridinger@providence.org</email>
    </contact>
    <investigator>
      <last_name>Jacob Abraham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Geisinger Clinic</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susan Kilbride</last_name>
      <phone>570-271-8492</phone>
      <email>sakilbride@geisinger.edu</email>
    </contact>
    <investigator>
      <last_name>Shikhar Agarwal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pinnacle Health Cardiovascular Institute</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Courtney Rodgers, RN, BSN, BC</last_name>
      <phone>717-639-6410</phone>
      <email>rodgerscl4@upmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Dawn MacFarlane, LPN, CRC</last_name>
      <phone>717-601-0300</phone>
      <email>macfarlanedm@upmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Hemal Gada, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Trump</last_name>
      <phone>717-531-5825</phone>
      <email>ptrump1@pennstatehealth.psu.edu</email>
    </contact>
    <investigator>
      <last_name>John Boehmer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agbenu Amali, MPH, MSN, RN</last_name>
      <phone>215-503-8954</phone>
      <email>Agbenu.amali@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Nicholas Ruggiero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Yeager</last_name>
      <phone>412-359-8468</phone>
      <email>Matthew.YEAGER@ahn.org</email>
    </contact>
    <investigator>
      <last_name>Manreet Kanwar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC Heart and Vascular Institute</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Melissa Enlow</last_name>
      <phone>412-647-1582</phone>
      <email>enlowms@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Saurabh Sanon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02904</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lori-Ann Desimone</last_name>
      <email>ldesimone@lifespan.org</email>
    </contact>
    <investigator>
      <last_name>Paul Gordon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debi Everidge, RN, BSN</last_name>
      <phone>843-792-2944</phone>
      <email>adamsde@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Daniel Steinberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>87232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherry Bowman</last_name>
      <phone>615-936-0061</phone>
      <email>sherry.bowman@vumc.org</email>
    </contact>
    <investigator>
      <last_name>Colin Barker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Heart</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Carpenter, RN</last_name>
      <phone>512-206-3603</phone>
      <email>Amanda.Carpenter2@HCAHealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Juhana Karha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Heart</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joan Morrison</last_name>
      <phone>832-633-5463</phone>
      <email>Joan.Morrison@HCAhealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Pranav Loyalka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine St. Luke's Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77020</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rene Plascencia</last_name>
      <phone>713-798-6027</phone>
      <email>rene.plascencia@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>Guilherme Silva, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>LaShawna Green</last_name>
      <phone>713-441-6548</phone>
      <email>lagreen2@HoustonMethodist.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie McCracken, MS, CCRC</last_name>
      <phone>469-814-4717</phone>
      <email>julie.mccracken@BSWHealth.org</email>
    </contact>
    <investigator>
      <last_name>Aasim Afzal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Methodist Healthcare System, San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gloria Carreon, RN, CCRC</last_name>
      <phone>210-575-3064</phone>
      <email>Gloria.Carreon@MHShealth.com</email>
    </contact>
    <investigator>
      <last_name>Jorge Alvarez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrianna Robison</last_name>
      <phone>801-507-4764</phone>
      <email>Adrianna.robison@imail.org</email>
    </contact>
    <investigator>
      <last_name>Brian Whisenant, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Bailes Bryceland, RN, CCRC</last_name>
    </contact>
    <investigator>
      <last_name>Sula Mazimba, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CJW Chippenham Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stephanie Burton</last_name>
      <phone>804-852-2747</phone>
      <email>Stephanie.burton@hcahealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Scott Lim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carilion Roanoke Memorial Hospital</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Bryant</last_name>
      <phone>540-853-0364</phone>
      <email>cdbryant@carilionclinic.org</email>
    </contact>
    <investigator>
      <last_name>Jason Foerst, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Donald Lobacz</last_name>
      <phone>414-649-3438</phone>
      <email>Donald.Lobacz@aah.org</email>
    </contact>
    <investigator>
      <last_name>Suhail Allaqaband, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2020</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Reduced Ejection Fraction</keyword>
  <keyword>Cardiomyopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

